Introducing Clenil
Clenil is the most widely used brand of ICS1 and is available in a pMDI across four different strengths:2–5
-
Clenil 50 micrograms
-
Clenil 200 micrograms
-
Clenil 100 micrograms
-
Clenil 250 micrograms
Clenil is indicated for the prophylactic management of mild, moderate, or severe asthma in adults2–5 or children (50 and 100 micrograms only).2,3
As part of a respiratory portfolio optimisation process, to better align with UK treatment guidelines, Clenil 50 and 250 microgram strengths will be discontinued in Q4 2026. The treatment plans of patients currently prescribed these products will need to be reviewed.
Find out more about these discontinuations here, and learn about recommendations for alternative treatments below.
